Selected publications from faculty, residents, and staff

November 8, 2019

Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR, Fuller CD, VanderWalde NA. JGO-00860; No. of pages: 4; 4C.

November 7, 2019

Validity of Veterans Health Administration structured data to determine accurate smoking status. Golden SE, Hooker ER, Shull S, Howard M, Crothers K, Thompson RF, Slatore CG. Health Informatics J. 2019 Nov 7:1460458219882259. doi: 10.1177/1460458219882259.

November 1, 2019

Current Issues and Techniques. Chandra RA, Kachnic LA, Thomas CR Jr. Hematol Oncol Clin North Am. 2019 Dec;33(6):xiii-xiv. doi: 10.1016/j.hoc.2019.09.001. Epub 2019 Oct 1.

October 29, 2019

Co-delivery of PARP and PI3K inhibitors by nanoscale metal–organic frameworks for enhanced tumor chemoradiation.  Neufeld M, DuRoss AN, Landry MR, Winter H, Goforth AM, Sun C. Nano Res. (2019).

October 24, 2019

Tumor Mutation Burden-From Doubts to Concerns. Wood MA, Nellore A, Thompson RF. JAMA Oncol. 2019 Oct 24. doi: 10.1001/jamaoncol.2019.4138.

October 21, 2019

Top Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency Expansion. Kahn J, Goodman CR, Albert A, Agarwal A, Jeans E, Tye K, Campbell S, Marcrom S, Colbert L. Received 22 May 2019, Accepted 4 July 2019, Available online 21 October 2019.

October 19, 2019

Top Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency Expansion. Kahn J, Goodman CR, Albert A, Agarwal A, Jeans E, Tye K, Campbell SR, Marcrom S, Colbert LE. Int J Radiat Oncol Biol Phys. 2019 Oct 19. pii: S0360-3016(19)33454-6. doi: 10.1016/j.ijrobp.2019.07.006

October 16, 2019

Arteriovenous malformation presenting as a symptomatic, enlarging and contrast-enhancing mass 12 years after being treated with embolization and radiotherapy. O'Neill BE, Uluc K, Wood MD, Jaboin J, Cetas JS, Ciporen J, Dogan A. World Neurosurg. 2019 Oct 16. pii: S1878-8750(19)32673-7. doi: 10.1016/j.wneu.2019.10.055

October 13, 2019

Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. Dengina N, Mitin T, Gamayunov S, Safina S, Kreinina Y, Tsimafeyeu I. ESMO Open 2019;4:e000535. doi: 10.1136/esmoopen-2019-000535

October 1, 2019

Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in Russia. McClelland S 3rd, Chernykh M, Dengina N, Gillespie EF, Likhacheva A, Usychkin S, Pankratov A, Kharitonova E, Egorova Y, Tsimafeyeu I, Tjulandin S, Thomas CR Jr, Mitin T. J Cancer Educ. 2019 Oct;34(5):871-873. doi: 10.1007/s13187-018-1388-7.

October 1, 2019

Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States. McClelland S 3rd, Degnin C, Chen Y, Watson GA, Jaboin JJ. J Neurooncol. 2019 Oct;145(1):159-165. doi: 10.1007/s11060-019-03283-z.

September 11, 2019

Artificial Intelligence in Radiation Oncology. Deig C, Kanwar A, Thompson R. Hematology/Oncology Clinics of North America. 11 Sept 2019.

September 4, 2019

Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States. McClelland S 3rd, Degnin C, Chen Y, Watson GA, Jaboin JJ. J Neurooncol. 2019 Sep 4. doi: 10.1007/s11060-019-03283-z.

September 1, 2019

Enhancing Career Paths for Tomorrow's Radiation Oncologists. Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):52-63. doi: 10.1016/j.ijrobp.2019.05.025

September 1, 2019

The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer. Mitin T, Choudhury A. World J Urol. 2019 Sep;37(9):1767-1772. doi: 10.1007/s00345-018-2480-7.

September 1, 2019

Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy. Pillai M, Adapa K, Das SK, Mazur L, Dooley J, Marks LB, Thompson RF, Chera BS. J Am Coll Radiol. 2019 Sep;16(9 Pt B):1267-1272. doi: 10.1016/j.jacr.2019.06.001.

August 28, 2019

Inhibition of Indoleamine 2,3 Dioxygenase Does Not Improve Cancer-Related Symptoms in a Murine Model of Human Papilloma Virus-Related Head and Neck Cancer. Vichaya EG, Vermeer DW, Budac D, Lee A, Grossberg A, Vermeer PD, Lee JH, Dantzer R. Int J Tryptophan Res. 2019 Aug 28;12:1178646919872508. doi: 10.1177/1178646919872508. eCollection 2019.

August 17, 2019

The surgical nature of radiation oncology should be better reflected in pre-residency training. McClelland S 3rd, Brown SA, Ramirez-Fort MK, Jaboin JJ, Zellars RC. Rep Pract Oncol Radiother. 2019 Sep-Oct;24(5):507-508. doi: 10.1016/j.rpor.2019.07.011. Epub 2019 Aug 17.

August 2, 2019

Evolving Practice Patterns in the Use of Prophylactic Cranial Irradiation for Extensive-Stage Small Cell Lung Cancer. Gjyshi O, Ludmir EB, Pezzi TA, Boyce-Fappiano D, Dursteler AE, Mitin T, Lin SH. JAMA Netw Open. 2019 Aug 2;2(8):e199135. doi: 10.1001/jamanetworkopen.2019.9135.

August 1, 2019

Germination of Germinoma Treatment. McClelland S 3rd, Jaboin JJ. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):967-968. doi: 10.1016/j.ijrobp.2018.03.040.

August 1, 2019

Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. Beeler WH, Griffith KA, Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Thomas CR Jr, Jagsi R. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):979-986. doi: 10.1016/j.ijrobp.2019.01.074.

July 26, 2019

Validation of the Emergency Severity Index (Version 4) for the Triage of Adult Emergency Department Patients With Active Cancer. Adler D, Abar B, Durham DD, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Coyne CJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Yeung SJ, Caterino JM. The Journal of Emergency Medicine. 2019 Jul 26. pii: S0736-4679(19)30418-4. doi: 10.1016/j.jemermed.2019.05.023.

July 25, 2019

The Tipping Point for Deep Learning in Oncology. Trister AD. JAMA Oncol. Published online July 25, 2019. doi:10.1001/jamaoncol.2019.1799

July 15, 2019

Enhancing chemoradiation of colorectal cancer through targeted delivery of raltitrexed by hyaluronic acid coated nanoparticles. Rosch JG, Landry MR, Thomas CR Jr, Sun C. Nanoscale. 2019 Aug 7;11(29):13947-13960. doi: 10.1039/c9nr04320a. Epub 2019 Jul 15.

July 11, 2019

Radiotherapy and Immunotherapy—Shining Further Together. Walker J, Loo BW. JAMA Oncol. Published online July 11, 2019. doi:10.1001/jamaoncol.2019.1448

July 4, 2019

Integrating nanomedicine into clinical radiotherapy regimens. DuRoss AN, Neufeld MJ, Rana S, Thomas CR Jr, Sun C. Adv Drug Deliv Rev. 2019 Jul 4. pii: S0169-409X(19)30083-3. doi: 10.1016/j.addr.2019.07.002.

July 2, 2019
Evolving Treatment Options and Future Directions for Locally Advanced Rectal Cancer. Chen EY, Kardosh A, Nabavizadeh N, Lopez CD. Clinical Colorectal Cancer. 2019 Jul 2. pii: S1533-0028(19)30234-8. doi: 10.1016/j.clcc.2019.06.005.

June 24, 2019

Assessing the Impact of Complementary and Alternative Medicine Trials in Oncology

Ethan B. Ludmir, MD1 , Amit Jethanandani, MPH1,2 , Walker Mainwaring, BA3 , Austin B. Miller, BS1,4 , Timothy A. Lin, BA1,3 , Andres F. Espinoza, BS3 , Aaron J. Grossberg, MD, PhD5 , and C. David Fuller, MD, PhD1

June 18, 2019
Am J Surg. 2019 Jun 18. pii: S0002-9610(19)30332-0. doi: 10.1016/j.amjsurg.2019.06.014. Rana S, Naik A, Pillai S, Vetto J, Pommier R, Kubicky CD.

June 3, 2019

JAMA Oncol.  2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055. Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH1, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD.

June 13, 2019

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT. BMC Cancer. 2019 Jun 13;19(1):572. doi: 10.1186/s12885-019-5805-z.

June 4, 2019

The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology. Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. J Natl Cancer Inst. 2019 Jun 4. pii: djz117. doi: 10.1093/jnci/djz117.

June 2019

Stop hedging your bets: reasons for non-adherence to a tri-modality regimen in the treatment of esophageal cancer in a multidisciplinary setting. Rahmani R, Koffler D, Haisley KR, Hunter JG, Poliakoff C, Thomas CR Jr, Holland JM, Dolan JP, Nabavizadeh N. J Gastrointest Oncol. 2019 Jun;10(3):387-390. doi: 10.21037/jgo.2019.01.24.